Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
Elisabeth SchorbJuergen FinkeGabriele IhorstBenjamin KasendaHeidi FrickerGerald IllerhausPublished in: BMC cancer (2019)
German clinical trials registry DRKS00011932 registered 18 August 2017.
Keyphrases
- stem cells
- high dose
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cell therapy
- randomized controlled trial
- blood brain barrier
- locally advanced
- radiation therapy
- mesenchymal stem cells
- stem cell transplantation
- patient reported outcomes
- patient reported
- community dwelling